Trevor Boudreaux, MD
Physical Medicine & Rehabilitation · Thibodaux, LANPI 1396286605
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $540 of the $625 with a category attached, or 86.4%. 10 manufacturers reported payments, led by Merz Pharmaceuticals, LLC at 34.5% of the total. 2025 is the largest year on record at $325, more than ten times the $12 reported in 2021.
Across 18 payments — averaging $34.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merz Pharmaceuticals, LLC$216
- Ipsen Biopharmaceuticals, Inc$182
- AbbVie$49
- Johnson & Johnson$45
- Nevro Corp.$36
- Si-bone, Inc.$26
- plus $71 from 4 others
What the payments were for
- Food & beverage$54086%
- Education$8514%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merz Pharmaceuticals, LLC | 2 | $216 |
| Ipsen Biopharmaceuticals, Inc | 4 | $182 |
| AbbVie | 3 | $49 |
| Johnson & Johnson | 2 | $45 |
| Nevro Corp. | 2 | $36 |
| Si-bone, Inc. | 1 | $26 |
| Globus Medical | 1 | $25 |
| Pacira Pharmaceuticals Incorporated | 1 | $19 |
| Vertex | 1 | $15 |
| Arbor Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XEOMIN$131
How this compares
$625 in reported general payments places this provider in the 65th percentile of 117 physical medicine & rehabilitation providers in Louisiana.
See all physical medicine & rehabilitation providers in Louisiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 286 | $3,235 |
| Pregabalin | 146 | $1,939 |
| Duloxetine Hcl | 118 | $1,311 |
| Baclofen | 55 | $952 |
| Methocarbamol | 18 | $418 |
| Clonazepam | 16 | $271 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 16 | $245 |
| Meloxicam | 51 | $182 |
| Cyclobenzaprine Hcl | 15 | $104 |
| Lorazepam | 13 | $12 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Thibodaux
- William RogenmoserAlexandria$350K
- Andrea ToomerMarrero$170K
- Taylor ColonCovington$26K
- Erik DavisMetairie$12K
- Stephen RynickMarrero$12K
- Fred DefranceschMetairie$11K
- Eric FinckeNew Orleans$9K
- Casey MurphyNew Orleans$8K
- Joshua KaufmanNew Orleans$8K
- Navneet SharmaRuston$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.